Answers are grounded in this paper and cite their sources.
[structure: see text] HIV-1 integrase is a critical enzyme for viral replication, and its inhibition is an emerging target for potential antiviral chemotherapy. We have discovered a novel inhibitor, integramycin, from screening of fermentation extracts using an in vitro assay. Integramycin possesses a hexacyclic ring system and exhibited an IC50 value of 4 microM against HIV-1 integrase (strand transfer). The isolation, structure elucidation, stereochemistry, conformation, and biological activity has been described.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: